ARCHIVES

Nexavar Phase III Trial Fails To Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Objections Delay GAO Report On Cancer Control

March 7, 1980

In Brief: Baque Heads Cancer Control Science Programs; Joftes, Davignon T Retire; Schepartz Returns

September 29, 1989

Cooperative Groups Fight to Keep CGOP Alive As DCPC, DCT Argue Over Who Pays

July 11, 1986

NCI contract Award

August 1, 1997

High Cervical Cancer Rates Indicate Access Problems

August 26, 2005

GSK Vaccine Prevents Lesions Associated With HPV

July 28, 2006